Journal
Journal for Immunotherapy of Cancer
Publication Date
10-15-2025
Volume
13
Issue
10
First Page
e011865
Document Type
Open Access Publication
DOI
10.1136/jitc-2025-011865
Rights and Permissions
Zhu L, Cheung YM, Chiang C, Gallagher EJ, Hamnvik OR, Mammen J, Quandt Z, Jones R, McDunn J, Al-Bahadili H, Angell T, Bancos I, Betof Warner A, Blackwell S, Calabrese C, Cho TA, Dougan M, Ferreira M, Funchain P, Herndon J, Johnson DB, Kennedy R, Kheterpal M, Khouri M, Lechner MG, Lim AM, Markova A, Meara A, Overton L, Perdigoto AL, Sachithanandan N, Sharon E, Spain L, Tsai K, Yarchoan M, Reynolds KL, Shariff A. Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors. J Immunother Cancer. 2025 Oct 15;13(10):e011865. doi: 10.1136/jitc-2025-011865. © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
Recommended Citation
Zhu, Ling; Al-Bahadili, Huda; and et al., "Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors." Journal for Immunotherapy of Cancer. 13, 10. e011865 (2025).
https://digitalcommons.wustl.edu/oa_4/6027
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
